InsiderDB
Sign inStart free trial

Rep. Maria Elvira Salazar sold Moderna (MRNA)

Rep. Maria Elvira Salazar (R-FL-27) · $1K–$15K · traded Sep 24, 2026

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Not stated
Traded
Sep 24, 2026
Disclosed
Oct 7, 2026
Days to disclose
13
Asset type
Stock
As filed
Moderna, Inc. - Common Stock
Industry
Biotechnology · Healthcare
Official filing ↗All of Salazar's tradesAll Congress trades in MRNA

Other trades in this filing

All of Salazar's trades →

Recent Congress trades in MRNA

Company context for MRNA

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. MRNAFinancial report·SEC EDGAR

    MRNA: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Nov 6, 2026, 4:06 PM ESTEvent / period: Sep 30, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  2. MRNACompany announcement·SEC EDGAR

    MRNA: Financial results

    Filed 8-K for an event or period dated 2026-11-06. Financial results.

    Public: Nov 6, 2026, 6:47 AM ESTEvent / period: Nov 6, 2026Original source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

  3. MRNALobbying report·Lobbying disclosures

    MRNA: third_quarter 2026 lobbying report

    Issues related to the Vaccine Injury Compensation Program (VICP); Issues related to vaccine safety and approval; Issues related to FDA's approval of Moderna's flu vaccine; Issues related to Messenger RNA (mRNA) therapies

    Public: Oct 20, 2026, 4:00 PM EDTOriginal source ↗

    2 congressional households disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.